New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

FTXHvsRSPHETF Comparison

ETF 1
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
-2%
Full FTXH fund page
VS
ETF 2
RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of
US Health Care
-2%
Full RSPH fund page

First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Invesco S&P 500® Equal Weight Health Care ETF (RSPH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.4% for RSPH. FTXH is up 2.6% year-to-date (YTD) with +$7M in YTD flows. RSPH performs worse with -3.61% YTD performance, and -$11M in YTD flows. Run a side-by-side ETF comparison of FTXH and RSPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FTXH vs RSPH performance and flow charts

Performance

-4.0-2.00.02.04.0%Feb 12Feb 20Feb 27Mar 6

Cumulative Flows

-8 M-6 M-4 M-2 M0 M2 M4 MFeb 12Feb 20Feb 27Mar 6

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/12/2026
1M3MYTD1Y3Y5Y
Perf.
FTXH
RSPH
-2.89%-4.32%
+3.86%-3.73%
+2.60%-3.61%
+22.74%+4.52%
+39.72%+12.14%
+37.82%+20.64%
Flows
FTXH
RSPH
+$4M-$8M
+$9M-$14M
+$7M-$11M
+$10M-$108M
-$13M-$319M
+$7M-$178M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FTXH
RSPH
+15.86%+14.92%
+20.64%+18.48%
+15.91%+14.79%
+15.69%+16.15%
Max drawdown
FTXH
RSPH
-5.21%-7.81%
-16.42%-10.79%
-19.32%-17.06%
-19.32%-21.91%
Max drawdown duration
FTXH
RSPH
11d11d
165d197d
393d192d
393d817d
Trading data

Create an account to view trading data

Join for free
FTXH
RSPH
Last sale
3/12/2026 at 1:30 PM
$33.83
$30.55
Previous close
03/12/2026
$34.46
$30.71
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FTXH
RSPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
FTXH
RSPH
Last price
$33.83
$30.55
1D performance
-1.82%
-0.52%
AuM$28.72 M$714.08 M
E/R0.6%0.4%
Characteristics
FTXH
RSPH
Management strategyPassivePassive
ProviderFirst TrustInvesco
BenchmarkNASDAQ US Smart Pharmaceuticals IndexS&P 500 Equal Weight Health Care Index
N° of holdings4957
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 20, 2016November 1, 2006
ESGNoNo
Advertisement
Exposure

Countries

FTXH
USA
95.63%
Other
4.37%
RSPH
USA
96.78%
Other
3.22%

Sectors

FTXH
Health Care
98.8%
Other
1.2%
RSPH
Health Care
93.72%
Other
6.28%
Advertisement

Diversification

FTXH

Total weight of top 15 holdings out of 15

71.63%
RSPH

Total weight of top 15 holdings out of 15

27.75%

Top 15 holdings

Data as of January 31, 2026
FTXH
MERCK & CO INC
7.83%
JOHNSON&JOHNSON
7.66%
BRISTOL-MYERS SQUIBB
6.97%
PFIZER
6.38%
ABBVIE
6.33%
CARDINAL HEALTH
4.31%
LILLY
4.23%
BIOGEN INC
3.99%
REGENERON PHARMACEUTICALS
3.81%
GILEAD SCIENCES
3.75%
VIATRIS INC
3.71%
VERTEX PHARMACEUTICALS
3.59%
AMGEN-T
3.55%
UTD THERAPEUT
3.14%
ZOETIS INC
2.38%
RSPH
MODERNA INC
2.64%
MOLINA HLTHCRE
2.00%
CENTENE
1.91%
CHRLS RIVER LABS
1.82%
GILEAD SCIENCES
1.81%
VIATRIS INC
1.81%
BIO-TECHNE CORP
1.78%
AMGEN-T
1.77%
PERKINELMER
1.77%
ELEVANCE HEALTH INC
1.76%
MERCK & CO INC
1.76%
THERMO FISHER SCIENTIFIC
1.74%
DEXCOM
1.73%
INCYTE
1.72%
BAXTER INTL
1.72%
Frequently asked questions about FTXH and RSPH

How have the FTXH and RSPH ETFs performed in 2026?

As of March 12, 2026, FTXH is up 2.6% year-to-date (YTD), while RSPH has lost -3.61%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: FTXH or RSPH?

Year-to-date, the FTXH ETF saw +$7M in flows, compared to -$11M for RSPH.

Which ETF is more volatile: FTXH or RSPH?

Over the past year, FTXH had a volatility of 20.64%, while RSPH experienced 18.48%.

Which ETF is bigger: FTXH or RSPH?

As of March 12, 2026, FTXH holds $28.72 M in assets under management (AUM), while RSPH manages $714.08 M.

What sectors do the FTXH and RSPH ETFs invest in?

FTXH leans toward sectors like Health Care. Meanwhile, RSPH focuses on Health Care.

What are the top holdings of the FTXH ETF and RSPH ETF?

FTXH top holdings include MERCK & CO INC, JOHNSON&JOHNSON and BRISTOL-MYERS SQUIBB. RSPH holds in its top three: MODERNA INC, MOLINA HLTHCRE and CENTENE.

Which ETF is more diversified: FTXH or RSPH?

FTXH holds 50 securities with 71.63% of its assets in the top 15. RSPH has 60 securities and a top 15 weight of 27.75%.

Advertisement
Latest news about FTXH & RSPH
Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up